XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes to Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect Period of Adoption Adjusted Balance [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect Period of Adoption Adjusted Balance [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect Period of Adoption Adjusted Balance [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect Period of Adoption Adjusted Balance [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect Period of Adoption Adjusted Balance [Member]
Beginning balance at Dec. 31, 2021 $ 297,167     $ 122,674   $ (11,724)   $ 189,401     $ (3,184)  
Beginning balance, shares at Dec. 31, 2021       13,066,233                
Net Income (Loss) 32,515             32,515        
Other comprehensive income (loss) (35,049)                   (35,049)  
Issuance of common stock in acquisition, shares       500,426                
Issuance of common stock in acquisition, net off repurchases 13,443     $ 13,446   (3)            
Issuance of common stock in acquisition, net off repurchases, shares       500,301                
Purchase of treasury stock (308)         (308)            
Purchase of treasury stock, shares       (9,488)                
Issuance of restricted stock (Net of forfeitures)       $ (1,522)   428   1,094        
Issuance of restricted stock (Net of forfeitures), Shares       48,496                
Stock-based compensation expense 899     $ 899                
Director stock awards 120         34   86        
Director stock awards, shares       2,880                
Cash dividends declared (10,647)             (10,647)        
Ending balance at Dec. 31, 2022 298,140 $ (3,371) $ 294,769 $ 135,497 $ 135,497 (11,573) $ (11,573) 212,449 $ (3,371) $ 209,078 (38,233) $ (38,233)
Ending balance, shares at Dec. 31, 2022       13,608,422 13,608,422              
Net Income (Loss) 22,787             22,787        
Other comprehensive income (loss) 9,221                   9,221  
Purchase of treasury stock (218)         (218)            
Purchase of treasury stock, shares       (10,704)                
Issuance of restricted stock (Net of forfeitures)       $ (1,263)   641   622        
Issuance of restricted stock (Net of forfeitures), Shares       57,875                
Stock-based compensation expense 1,281     $ 1,281                
Director stock awards 180         110   70        
Director stock awards, shares       9,048                
Cash dividends declared (11,477)             (11,477)        
Ending balance at Dec. 31, 2023 316,543     $ 135,515   (11,040)   221,080     (29,012)  
Ending balance, shares at Dec. 31, 2023       13,664,641                
Net Income (Loss) 25,938             25,938        
Other comprehensive income (loss) 3,789                   3,789  
Purchase of treasury stock (664)         (664)            
Purchase of treasury stock, shares       (28,391)                
Issuance of restricted stock (Net of forfeitures)       $ (1,311)   608   703        
Issuance of restricted stock (Net of forfeitures), Shares       54,358                
Stock-based compensation expense 1,361     $ 1,361                
Director stock awards 188         111   77        
Director stock awards, shares       8,928                
Cash dividends declared (11,944)             (11,944)        
Ending balance at Dec. 31, 2024 $ 335,211     $ 135,565   $ (10,985)   $ 235,854     $ (25,223)  
Ending balance, shares at Dec. 31, 2024       13,699,536